Cardiol Therapeutics Overview

Cardiol Therapeutics Operating Income

Operating Income for CRDL.

Quarterly Operating Income

$-9731878.00

↑ 15.46% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-35619111.00

↑ 120.27% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin